Jacobs Levy Equity Management Portfolio holdings
Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$325M |
| 2 |
CrowdStrike
CRWD
|
+$225M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$186M |
| 4 |
Sandisk
SNDK
|
+$155M |
| 5 |
Sysco
SYY
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$418M |
| 2 |
ServiceNow
NOW
|
+$262M |
| 3 |
Apple
AAPL
|
+$260M |
| 4 |
Masco
MAS
|
+$163M |
| 5 |
Roku
ROKU
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.14% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Yext
YEXT
$759M
| $416K | ﹤0.01% |
+89,039
| New | +$346K |
2026 Q2
0 quarters
|
|
852
Builders FirstSource
BLDR
$6.53B
| $415K | ﹤0.01% |
4,635
+1,085
| +31% | +$86.7K |
2023 Q1
13 quarters
|
|
853
First Western Financial
MYFW
$307M
| $412K | ﹤0.01% |
+12,833
| New | +$365K |
2026 Q2
0 quarters
|
|
854
AMERISAFE
AMSF
$361M
| $412K | ﹤0.01% |
12,168
-5,465
| -31% | -$173K |
2024 Q2
8 quarters
|
|
855
8x8 Inc
EGHT
$337M
| $409K | ﹤0.01% |
239,063
-333,868
| -58% | -$672K |
2025 Q1
5 quarters
|
|
856
Kodiak Sciences
KOD
$6.99B
| $405K | ﹤0.01% |
10,395
-30,544
| -75% | -$1.19M |
2022 Q3
15 quarters
|
|
857
Trupanion
TRUP
$1.49B
| $395K | ﹤0.01% |
15,957
-635
| -4% | -$15.4K |
2024 Q4
6 quarters
|
|
858
Definitive Healthcare
DH
$140M
| $393K | ﹤0.01% |
472,710
+173,237
| +58% | +$159K |
2025 Q4
2 quarters
|
|
859
Johnson Controls International
JCI
$84.4B
| $387K | ﹤0.01% |
+2,647
| New | +$374K |
2026 Q2
0 quarters
|
|
860
Murphy Oil
MUR
$5.28B
| $373K | ﹤0.01% |
+11,471
| New | +$439K |
2026 Q2
0 quarters
|
|
861
Plumas Bancorp
PLBC
$436M
| $371K | ﹤0.01% |
+6,346
| New | +$336K |
2026 Q2
0 quarters
|
|
862
Seer Inc
SEER
$87.6M
| $369K | ﹤0.01% |
222,332
+79,090
| +55% | +$143K |
2023 Q1
13 quarters
|
|
863
MNTN Inc
MNTN
$382M
| $367K | ﹤0.01% |
39,927
-2,297
| -5% | -$20.9K |
2025 Q3
3 quarters
|
|
864
Figure Technology Solutions
FIGR
$5.68B
| $364K | ﹤0.01% |
+11,844
| New | +$396K |
2026 Q2
0 quarters
|
|
865
MFA Financial
MFA
$588M
| $364K | ﹤0.01% |
37,525
| – | – |
2025 Q4
2 quarters
|
|
866
Gossamer Bio
GOSS
$67.1M
| $360K | ﹤0.01% |
27,343
+6,154
| +29% | +$137K |
2023 Q4
10 quarters
|
|
867
Holley
HLLY
$302M
| $359K | ﹤0.01% |
140,738
+18,795
| +15% | +$53.3K |
2025 Q4
2 quarters
|
|
868
Beta Bionics
BBNX
$893M
| $358K | ﹤0.01% |
22,843
-91,876
| -80% | -$1.09M |
2025 Q3
3 quarters
|
|
869
Novavax
NVAX
$1.41B
| $349K | ﹤0.01% |
37,027
-74,240
| -67% | -$665K |
2025 Q2
4 quarters
|
|
870
Comtech Telecommunications
CMTL
$36.2M
| $342K | ﹤0.01% |
163,046
+111,116
| +214% | +$427K |
2025 Q3
3 quarters
|
|
871
MaxCyte
MXCT
$123M
| $332K | ﹤0.01% |
270,265
-505,959
| -65% | -$504K |
2025 Q4
2 quarters
|
|
872
APA Corp
APA
$16.3B
| $332K | ﹤0.01% |
+10,201
| New | +$383K |
2026 Q2
0 quarters
|
|
873
Instil Bio
TIL
$41.2M
| $331K | ﹤0.01% |
+43,051
| New | +$347K |
2026 Q2
0 quarters
|
|
874
Scilex Holding
SCLX
$10.1M
| $321K | ﹤0.01% |
+41,163
| New | +$302K |
2026 Q2
0 quarters
|
|
875
The RealReal
REAL
$1.81B
| $320K | ﹤0.01% |
27,171
-40,392
| -60% | -$431K |
2026 Q1
1 quarter
|
|
Similar funds
Jacobs Levy Equity Management's Q2 2026 Portfolio in Review
As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
- Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
- Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
- Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
- Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
- Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.